Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Byrna Technologies Inc (BYRN) vs Cronos Group Inc (CRON) Price & Performance

Byrna Technologies IncTrade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Byrna Technologies Inc vs Cronos Group Inc — how do they compare? Byrna Technologies Inc trades at $4.68 (market cap $109.84M), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Cronos Group Inc is far larger — about 10.1× Byrna Technologies Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Byrna Technologies Inc nearer its low. Which is the better fit depends on your goals.

BYRNCRON
Market Cap
$109.84M$1.11B
Sector
TechnologyHealth
52-Week High
$27.63$3.27
52-Week Low
$3.18$2.30
Enterprise Value
$101.44M$310.67M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Byrna Technologies Inc

BYRN trades at $4.45, up 2.06% today, but faces bearish technical signals and recent earnings challenges. The company reported a Q2 2026 loss of $0.44 per share, missing estimates, with revenue declining 42.5% year-over-year. Despite a 71.4% analyst buy rating, negative net income margin and cash flow concerns highlight operational headwinds. Recent management appointments aim to revitalize marketing and retail growth.

Outlook remains cautious due to weak sales trends and profitability issues, though strategic hires and acquisitions could support a turnaround. Key risks include sustained revenue declines and competitive pressures. Investors should weigh analyst optimism against fundamental weaknesses before considering a position.

Cronos Group Inc

CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.

Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Byrna Technologies Inc

Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.

Read more on BYRN

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON